
Sign up to save your podcasts
Or


In this episode of Denatured, Dr. Peter Marks M.D., PhD. gives his thoughts on the future of cell and gene therapies. He speaks candidly about opportunities and realities, manufacturing and its role in efficacy and the CGT runway.
Dr. Marks was keynote speaker at the GenScript Biotech Forum in San Francisco this week.
Host
Lori Ellis, Head of Insights, BioSpace
Guest
Peter Marks M.D., PhD., Director, Center for Biologics Evaluation and Research (CBER)
By BioSpace4.9
1313 ratings
In this episode of Denatured, Dr. Peter Marks M.D., PhD. gives his thoughts on the future of cell and gene therapies. He speaks candidly about opportunities and realities, manufacturing and its role in efficacy and the CGT runway.
Dr. Marks was keynote speaker at the GenScript Biotech Forum in San Francisco this week.
Host
Lori Ellis, Head of Insights, BioSpace
Guest
Peter Marks M.D., PhD., Director, Center for Biologics Evaluation and Research (CBER)

90,841 Listeners

30,814 Listeners

43,719 Listeners

8,760 Listeners

954 Listeners

4,362 Listeners

1,176 Listeners

1,971 Listeners

56,879 Listeners

9,572 Listeners

323 Listeners

6,072 Listeners

6,564 Listeners

34 Listeners

21 Listeners